A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : Tmax / time to maximum concentration

[Related PubMed/MEDLINE]
Total Number of Papers: 386
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   Tmax  (>> Co-occurring Abbreviation)
Long Form:   time to maximum concentration
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A pharmacokinetic assessment of optimal dosing, preparation and chronotherapy of aspirin in pregnancy. CL, Cmax, EC, LC-MS, SA, Vd
2019 A Randomized, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects. AEs, AUC, s.c
2019 Absolute Bioavailability of Osimertinib in Healthy Adults. EGFR-TKI, PK
2019 Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles. CL, PK, Quesero XR, Seroquel XR
2019 Evaluation of the Pharmacokinetics of Abiraterone Acetate and Abiraterone Following Single-Dose Administration of Abiraterone Acetate to Healthy Subjects. AUC, LLOQ
2019 Ivermectin environmental impact: Excretion profile in sheep and phytotoxic effect in Sinapis alba. AUC, IVM, MRT
2019 Ivermectin environmental impact: Excretion profile in sheep and phytotoxic effect in Sinapis alba. AUC, IVM, MRT
2019 Pharmacokinetic and Pharmacodynamic Properties of a Micro-Dose Nasal Spray Formulation of Desmopressin (AV002) in Healthy Water-Loaded Subjects. s.c
2019 Pharmacokinetic effects of endotracheal, intraosseous, and intravenous epinephrine in a swine model of traumatic cardiac arrest. Cmax, CPRD, HIO, IO, ROSC, SIO, TCA, TIO
10  2019 Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed-Dose Combination IBU/Caffeine (400/100mg; FDC) in Comparison With 400mg IBU as Acid or Lysinate Under Fasted and Fed Conditions-Data From 2 Single-Center, Single-Dose, Randomized Crossover Studies in Healthy Volunteers. AUC, FDC, IBU, PK
11  2019 Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors. CI
12  2019 Pharmacokinetics and ex vivo anti-inflammatory effects of oral misoprostol in horses. EP, MFA
13  2019 Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study. LCPT, PK
14  2019 Pharmacokinetics of the 1.5 mg levonorgestrel emergency contraceptive in women with normal, obese and extremely obese body mass index. AUC, BMI, CL, PK
15  2019 Phase I study of orally administered 14Carbon-isotope labelled-vistusertib (AZD2014), a dual TORC1/2 kinase inhibitor, to assess the absorption, metabolism, excretion, and pharmacokinetics in patients with advanced solid malignancies. PK, TORC
16  2019 Rats and rabbits as pharmacokinetic screening tools for long acting intramuscular depots: case study with paliperidone palmitate suspension. AUC, SD
17  2019 The pharmacokinetics of moxidectin following intravenous and topical administration to swine. BW, CL, MRT, MXD
18  2018 A Comparison of the Pharmacokinetics of Methylphenidate Extended-Release Orally Disintegrating Tablets With a Reference Extended-Release Formulation of Methylphenidate in Healthy Adults. ER, MPH, MPH XR-ODT, PK
19  2018 A nasal abuse potential randomized clinical trial of REMOXY ER, a high-viscosity extended-release oxycodone formulation. Emax, IR
20  2018 A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects. AEs, AUCtau, CBD, PK
21  2018 Accelerated Development of the Dual Orexin Receptor Antagonist ACT-541468: Integration of a Microtracer in a First-in-Human Study. DORA, i.v, PD, PK
22  2018 Antiobesity and emetic effects of a short-length peptide YY analog and its PEGylated and alkylated derivatives. DIO, PEG, Y2R
23  2018 Comparison of xenobiotic metabolism in phase I oxidation and phase II conjugation between rats and bird species. AUC, GST, MRT, PAH, PYDOGS, SULT, UGT, Vmax
24  2018 Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone and estradiol: pharmacokinetics from a dose-finding study. Cmax, CVR, NES, PK
25  2018 Development of an Abbreviated Mycophenolic Acid Area Under the Time-Concentration Curve for Renal Transplant Patients Under Enteric-Coated Mycophenolate Sodium: A Comparison With Critical Analysis of Available Equations. AUC, eAUC, HPLC, MPA
26  2018 Effect of Puerarin on the Pharmacokinetics of Baicalin in Gegen Qinlian Decoction () in Mice. BAL, icELISA, mAb, Pue
27  2018 Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD. AEs, CI, MPH XR-ODT
28  2018 Improved Human Pharmacokinetic Prediction of Hepatically Metabolized Drugs With Species-Specific Systemic Clearance. AUC, PBPK, PK, Vdss
29  2018 In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits. BID, HPLC, NSAIDs
30  2018 Intrapulmonary Pharmacokinetics of Lascufloxacin in Healthy Adult Volunteers. AUC0-24
31  2018 Metoclopramide nasal spray in vitro evaluation and in vivo pharmacokinetic studies in dogs. IM, MCP
32  2018 Pharmacokinetic Characterization of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults. THC
33  2018 Pharmacokinetic characterization of three novel 4-mg nicotine lozenges
34  2018 Pharmacokinetic evaluation of quetiapine fumarate controlled release hybrid hydrogel: a healthier treatment of schizophrenia. GA, Gel, HPMC
35  2018 Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Healthy Chinese Subjects. AUC, rhIL-1ra
36  2018 Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study. AUC
37  2018 Pharmacokinetics of a Single Dose of Oral and Intramuscular Meloxicam in African Penguins ( Spheniscus demersus). NSAID
38  2018 Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin-naive type 2 diabetes. CKD4, CrCl, PK
39  2018 Pharmacokinetics of multiple doses of transdermal flunixin meglumine in adult Holstein dairy cows. HPLC-MS
40  2018 Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects. AUC30min, CIs, DPI
41  2018 Preliminary pharmacokinetics of intravenous and subcutaneous dolasetron and pharmacodynamics of subcutaneous dolasetron in healthy cats. AUClast, PD, PK, s.c
42  2018 Serum levetiracetam concentrations and adverse events after multiple dose extended release levetiracetam administration to healthy cats. XRL
43  2018 Sternal Route More Effective than Tibial Route for Intraosseous Amiodarone Administration in a Swine Model of Ventricular Fibrillation. SIO, TIO, VF
44  2018 The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults. BGF MDI, COPD, PK
45  2017 Absolute Bioavailability of Ponesimod, a Selective S1P1 Receptor Modulator, in Healthy Male Subjects. CI, CL
46  2017 Clinical Pharmacokinetics of Paritaprevir. AUC, DAAs, HCV, NS
47  2017 Combined Influence of Genetic Polymorphism and DNA Methylation on ABCB1 Expression and Function in Healthy Chinese Males. ABCB1
48  2017 Efficacy of guar gum-based ronidazole capsules as a treatment for Tritrichomonas foetus infection in cats. AUC
49  2017 Evaluation of the analgesic and pharmacokinetic properties of transdermally administered fentanyl in goats. FEN, TFPs
50  2017 Garenoxacin pharmacokinetics in patients undergoing maintenance hemodialysis. GRNX, MH
51  2017 Iron Pharmacokinetics in Women with Iron Deficiency Anaemia Following A Single Oral Dose of a Novel Formulation of Tardyferon (Prolonged Release Ferrous Sulphate). IDA
52  2017 Pharmacokinetic based study on "lagged stimulation" of Curcumae Longae Rhizoma - Piper nigrum couplet in their main active components' metabolism using UPLC-MS-MS. ESI, IS, LLE, LLOQ, SRM
53  2017 Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes. LOQ, THC
54  2017 Pharmacokinetic profiles of the active metamizole metabolites in healthy horses. AA, i.v, IM, MAA, MT
55  2017 Pharmacokinetics after a single dose of naloxone administered as a nasal spray in healthy volunteers. ---
56  2017 Pharmacokinetics of a new, nasal formulation of naloxone. ---
57  2017 Pharmacokinetics of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Children with Attention-Deficit/Hyperactivity Disorder. ADHD, AMP XR-ODTs, AUCinf, CIs, PK
58  2017 Pharmacokinetics of a novel spot-on formulation of praziquantel for dogs. MS/MS, PZQ, UPLC
59  2017 Plasma profile of cimicoxib in sheep after oral administration at two different rates. ---
60  2017 Quantification of Etodolac in Human Plasma for Pharmacokinetics and Bioequivalence Studies in 27 Korean Subjects. AUCt, IS, MRM
61  2017 Quantitative prediction of histamine H1 receptor occupancy by the sedative and non-sedative antagonists in the human central nervous system based on systemic exposure and preclinical data. BBB, CNS, RO
62  2017 Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects. ABX464-NGlc
63  2017 Saliva Versus Plasma Bioequivalence of Azithromycin in Humans: Validation of Class I Drugs of the Salivary Excretion Classification System. SECS
64  2017 Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers. AEs, CK, PPD
65  2017 The pharmacokinetics of oral ketoprofen in patients after gastric resection. HPLC, NSAID, PK
66  2017 The Resuscitative and Pharmacokinetic Effects of Humeral Intraosseous Vasopressin in a Swine Model of Ventricular Fibrillation. AHA, ANOVA, CA, HIO, IO, MANOVA, ROSC, VF
67  2017 Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study. ---
68  2017 Urinary Kinetics of Heroin Metabolites in Pigs Shortly After Intake. M3G
69  2017 Vasculoprotective and vasodilatation effects of herbal formula (Sahatsatara) and piperine in spontaneously hypertensive rats. NO, NWR, SHR, UPLC
70  2016 A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults. CI, PK
71  2016 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers. AEs
72  2016 A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. ADHD, AEs, MPH, MPH XR-ODTs, PK
73  2016 A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteers. IR, QTcI
74  2016 A validated LC-MS/MS determination method for the illegal food additive rhodamine B: Applications of a pharmacokinetic study in rats. ---
75  2016 Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog) 100 U/mL. Gtot, IL200, PD, PK
76  2016 Bioequivalence Study of Two Long-Acting Formulations of Oxytetracycline Following Intramuscular Administration in Bovines. OTC
77  2016 Ceftiofur pharmacokinetics in Nile tilapia Oreochromis niloticus after intracardiac and intramuscular administrations. AUC, IC, IM
78  2016 Comparative Plasma and Cerebrospinal Fluid Pharmacokinetics of Paracetamol After Intravenous and Oral Administration. AUCs, CIs, Cmax, CSF
79  2016 Dissolving microneedle-based intradermal delivery of interferon-alpha-2b. AUC, IFN, IM, MNs
80  2016 Effect of intramuscular methadone on pharmacokinetic data and thermal and mechanical nociceptive thresholds in the cat. CI, IM
81  2016 Effects of humerus intraosseous versus intravenous amiodarone administration in a hypovolemic porcine model. HIO, ROSC
82  2016 Effects of Intraosseous Tibial vs. Intravenous Vasopressin in a Hypovolemic Cardiac Arrest Model. CPR, IO, ROSC
83  2016 Effects of tibial and humerus intraosseous administration of epinephrine in a cardiac arrest swine model. Cmax, HIO, ROSC, TIO
84  2016 Effects of tibial and humerus intraosseous and intravenous vasopressin in porcine cardiac arrest model. Cmax, HIO, ROSC, TIO
85  2016 Effects of tibial intraosseous and IV administration of vasopressin on kinetics and survivability in cardiac arrest. Cmax, ROSC, TIO
86  2016 Improving Biopharmaceutical Properties of Vinpocetine Through Cocrystallization. AUC
87  2016 Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent. 18F-FDS, DTPA
88  2016 Is it appropriate regarding patient preference to take Myrtol standardized enteric-coated soft capsules after a meal rather than at fasted state? A food-drug pharmacokinetic interaction study in healthy Chinese volunteers. ---
89  2016 Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. CI, e-cigarette, PG, VG
90  2016 Overview of extended release tacrolimus in solid organ transplantation. Cmax
91  2016 Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor-Free Renal Transplant Recipients. AUC, CNI, EC-MPS, MMF, MPA
92  2016 Pharmacokinetics and cardiovascular effects following a single oral administration of a nonaqueous pimobendan solution in healthy dogs. CHF, UHPLC-MS
93  2016 Pharmacokinetics of Ferrous Sulphate (Tardyferon) after Single Oral Dose Administration in Women with Iron Deficiency Anaemia. IDA
94  2016 Pharmacokinetics of Glycopyrronium Following Repeated Once-Daily Inhalation in Healthy Chinese Subjects. AUC
95  2016 Pharmacokinetics of Rasagiline in Healthy Adult Chinese Volunteers with Various Genotypes: A Single-Center, Open-Label, Multiple-Dose Study. AI
96  2016 Pharmacokinetics of sternal intraossesous atropine administration in normovolemic and hypovolemic swine. IO
97  2016 Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone - results from first-in-man and relative bioavailability studies. AUC, IR, PEG
98  2016 Simultaneous Determination of Purpurin, Munjistin and Mollugin in Rat Plasma by Ultra High Performance Liquid Chromatography-Tandem Mass Spectrometry: Application to a Pharmacokinetic Study after Oral Administration of Rubia cordifolia L. Extract. ESI, LLE, MRM
99  2016 Single- and Multiple-Dose Milnacipran Pharmacokinetics in Healthy Han Chinese Volunteers. AEs, AUC
100  2016 Stereoselective Pharmacodynamics and Pharmacokinetics of Proton Pump Inhibitors. AUC, PPIs